481 related articles for article (PubMed ID: 26256008)
21. Risk of death associated with new benzodiazepine use among persons with Alzheimer disease: A matched cohort study.
Saarelainen L; Tolppanen AM; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H
Int J Geriatr Psychiatry; 2018 Apr; 33(4):583-590. PubMed ID: 29143367
[TBL] [Abstract][Full Text] [Related]
22. Prescription of benzodiazepines, z-drugs, and gabapentinoids and mortality risk in people receiving opioid agonist treatment: Observational study based on the UK Clinical Practice Research Datalink and Office for National Statistics death records.
Macleod J; Steer C; Tilling K; Cornish R; Marsden J; Millar T; Strang J; Hickman M
PLoS Med; 2019 Nov; 16(11):e1002965. PubMed ID: 31770388
[TBL] [Abstract][Full Text] [Related]
23. First trimester exposure to anxiolytic and hypnotic drugs and the risks of major congenital anomalies: a United Kingdom population-based cohort study.
Ban L; West J; Gibson JE; Fiaschi L; Sokal R; Doyle P; Hubbard R; Smeeth L; Tata LJ
PLoS One; 2014; 9(6):e100996. PubMed ID: 24963627
[TBL] [Abstract][Full Text] [Related]
24. Use of benzodiazepines, hypnotics, and anxiolytics in major depressive disorder: association with chronic pain diseases.
Liu X; Ye W; Watson P; Tepper P
J Nerv Ment Dis; 2010 Aug; 198(8):544-50. PubMed ID: 20699718
[TBL] [Abstract][Full Text] [Related]
25. Driving performance and neurocognitive skills of long-term users of benzodiazepine anxiolytics and hypnotics.
van der Sluiszen NNJJM; Vermeeren A; Verster JC; van de Loo AJAE; van Dijken JH; Veldstra JL; Brookhuis KA; de Waard D; Ramaekers JG
Hum Psychopharmacol; 2019 Nov; 34(6):e2715. PubMed ID: 31837049
[TBL] [Abstract][Full Text] [Related]
26. Risk of pneumonia associated with incident benzodiazepine use among community-dwelling adults with Alzheimer disease.
Taipale H; Tolppanen AM; Koponen M; Tanskanen A; Lavikainen P; Sund R; Tiihonen J; Hartikainen S
CMAJ; 2017 Apr; 189(14):E519-E529. PubMed ID: 28396328
[TBL] [Abstract][Full Text] [Related]
27. Benzodiazepine use in Belgian nursing homes: a closer look into indications and dosages.
Bourgeois J; Elseviers MM; Azermai M; Van Bortel L; Petrovic M; Vander Stichele RR
Eur J Clin Pharmacol; 2012 May; 68(5):833-44. PubMed ID: 22189673
[TBL] [Abstract][Full Text] [Related]
28. A population-based cohort study of anxiety, depression, sleep and alcohol outcomes among benzodiazepine and z-hypnotic users.
Nordfjærn T
Addict Behav; 2012 Oct; 37(10):1151-7. PubMed ID: 22704915
[TBL] [Abstract][Full Text] [Related]
29. [Benzodiazepines and sleep].
Ansseau M
Acta Psychiatr Belg; 1985; 85(4):522-32. PubMed ID: 2865871
[TBL] [Abstract][Full Text] [Related]
30. Benzodiazepines--a necessary evil? A survey of prescribing at a specialist UK psychiatric hospital.
Haw C; Stubbs J
J Psychopharmacol; 2007 Aug; 21(6):645-9. PubMed ID: 17092967
[TBL] [Abstract][Full Text] [Related]
31. Hypnotics and Triazolobenzodiazepines--Best Predictors of High-Dose Benzodiazepine Use: Results from the Luxembourg National Health Insurance Registry.
Cloos JM; Bocquet V; Rolland-Portal I; Koch P; Chouinard G
Psychother Psychosom; 2015; 84(5):273-83. PubMed ID: 26278327
[TBL] [Abstract][Full Text] [Related]
32. Mortality associated with anxiolytic and hypnotic drugs-A systematic review and meta-analysis.
Parsaik AK; Mascarenhas SS; Khosh-Chashm D; Hashmi A; John V; Okusaga O; Singh B
Aust N Z J Psychiatry; 2016 Jun; 50(6):520-33. PubMed ID: 26590022
[TBL] [Abstract][Full Text] [Related]
33. Benzodiazepine-like hypnotics and the associated risk of road traffic accidents.
Orriols L; Philip P; Moore N; Castot A; Gadegbeku B; Delorme B; Mallaret M; Lagarde E;
Clin Pharmacol Ther; 2011 Apr; 89(4):595-601. PubMed ID: 21368756
[TBL] [Abstract][Full Text] [Related]
34. An approach to reduce benzodiazepine and cyclopyrrolone use in general practice : a study based on a Danish population.
Jørgensen VR
CNS Drugs; 2007; 21(11):947-55. PubMed ID: 17927298
[TBL] [Abstract][Full Text] [Related]
35. Use of sedative-hypnotics and the risk of Alzheimer's dementia: A retrospective cohort study.
Lee J; Jung SJ; Choi JW; Shin A; Lee YJ
PLoS One; 2018; 13(9):e0204413. PubMed ID: 30248129
[TBL] [Abstract][Full Text] [Related]
36. Long-term benzodiazepine use: factors of importance and the development of individual use patterns over time--a 13-year follow-up in a Swedish community.
Isacson D
Soc Sci Med; 1997 Jun; 44(12):1871-80. PubMed ID: 9194248
[TBL] [Abstract][Full Text] [Related]
37. Anxiolytics, hypnotics, and antidepressants dispensed to adolescents in a French region in 2002.
Mancini J; Thirion X; Masut A; Saillard C; Pradel V; Romain F; Pastor MJ; Coudert C; Micallef J
Pharmacoepidemiol Drug Saf; 2006 Jul; 15(7):494-503. PubMed ID: 16700077
[TBL] [Abstract][Full Text] [Related]
38. Prescription and intake patterns in long-term and ultra-long-term benzodiazepine treatment in primary care practice.
Geiselmann B; Linden M
Pharmacopsychiatry; 1991 Mar; 24(2):55-61. PubMed ID: 1677204
[TBL] [Abstract][Full Text] [Related]
39. [Prescribing Trends of Benzodiazepine and other Sedatives in the Lisbon and Tagus Valley Regional Health Administration between 2013 and 2020: A Retrospective Study].
Gomes S; Broeiro-Gonçalves P; Meireles C; Caldeira D; Costa J; Guerreiro MP; Ribeiro N; Afonso R
Acta Med Port; 2023 Apr; 36(4):264-274. PubMed ID: 37029641
[TBL] [Abstract][Full Text] [Related]
40. Benzodiazepine use in an elderly community-dwelling population. Characteristics of users and factors associated with subsequent use.
Fourrier A; Letenneur L; Dartigues JF; Moore N; Bégaud B
Eur J Clin Pharmacol; 2001 Aug; 57(5):419-25. PubMed ID: 11599660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
